101
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

The Impact of COPD Exacerbations in the Year Following Pulmonary Rehabilitation: Secondary Analysis of a Randomised Controlled Trial

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , , , , , , & show all
Pages 3423-3431 | Published online: 31 Dec 2020

References

  • VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
  • PiquetJ, ChavaillonJM, DavidP, et al. High-risk patients following hospitalisation for an acute exacerbation of COPD. Eur Respir J. 2013;42(4):946–955. doi:10.1183/09031936.0018031223349446
  • Soler-CatalunaJJ, Martinez-GarciaMA, Roman SanchezP, SalcedoE, NavarroM, OchandoR. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
  • Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: gold executive summary. GOLD Published 2020. Accessed, 2020.
  • CelliBR, DecramerM, WedzichaJA, et al. An official american thoracic society/european respiratory society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(7):e4–e27. doi:10.1164/rccm.201501-0044ST25830527
  • McCarthyB, CaseyD, DevaneD, MurphyK, MurphyE, LacasseY. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Systematic Rev. 2015;2:Cd003793.
  • GriffithsTL, BurrML, CampbellIA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–368. doi:10.1016/S0140-6736(99)07042-710665556
  • HollandAE, MahalA, HillCJ, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017;72(1):57–65. doi:10.1136/thoraxjnl-2016-20851427672116
  • AlisonJA, McKeoughZJ, JohnstonK, et al. Australian and new zealand pulmonary rehabilitation guidelines. Respirology. 2017;22(4):800–819. doi:10.1111/resp.1302528339144
  • HollandAE, MahalA, HillCJ, et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease - a multi-centre randomised controlled equivalence trial. BMC Pulm Med. 2013;13:57. doi:10.1186/1471-2466-13-5724011178
  • WageckB, CoxNS, HollandAE. Recovery following acute exacerbations of chronic obstructive pulmonary disease - a review. Copd. 2019;16(1):93–103. doi:10.1080/15412555.2019.159896531044644
  • SpruitMA, SinghSJ, GarveyC, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.24127811
  • BurgeS, WedzichaJA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s. doi:10.1183/09031936.03.0007800212795331
  • Rodriguez-RoisinR. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5Suppl 2):398S–401S. doi:10.1378/chest.117.5_suppl_2.398S10843984
  • van den BergeM, HopWC, van der MolenT, et al. Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respir Res. 2012;13:44. doi:10.1186/1465-9921-13-4422672621
  • VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. gold executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
  • DalalAA, PatelJ, D’SouzaA, FarrellyE, NagarS, ShahM. Impact of COPD exacerbation frequency on costs for a managed care population. J Manag Care Spec Pharm. 2015;21(7):575–583.26108382
  • HollandAE, SpruitMA, TroostersT, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi:10.1183/09031936.0015031425359355
  • WilliamsJE, SinghSJ, SewellL, GuyattGH, MorganMD. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001;56(12):954–959. doi:10.1136/thorax.56.12.95411713359
  • BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
  • HillK, DolmageTE, WoonL, GoldsteinR, BrooksD. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax. 2010;65(6):486–491. doi:10.1136/thx.2009.12870220522844
  • HaskellWL, LeeIM, PateRR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423–1434. doi:10.1249/mss.0b013e3180616b2717762377
  • HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
  • AndreasS, RoverC, HeinzJ, StraubeS, WatzH, FriedeT. Decline of COPD exacerbations in clinical trials over two decades - a systematic review and meta-regression. Respir Res. 2019;20(1):186. doi:10.1186/s12931-019-1163-231420040
  • WilkinsonTMA, ArisE, BourneSC, et al. Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort. ERJ Open Res. 2019;5:1. doi:10.1183/23120541.00248-2018
  • PuhanMA, Gimeno-SantosE, CatesCJ, TroostersT. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005305.27930803
  • RochesterCL, SpruitMA. Maintaining the benefits of pulmonary rehabilitation. the holy grail. Am J Respir Crit Care Med. 2017;195(5):548–551. doi:10.1164/rccm.201609-1925ED28248138
  • CarrSJ, GoldsteinRS, BrooksD. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest. 2007;132(1):127–134. doi:10.1378/chest.07-026917475631
  • HererB, ChinetT. Acute exacerbation of COPD during pulmonary rehabilitation: outcomes and risk prediction. Int J Chron Obstruct Pulmon Dis. 2018;13:1767–1774. doi:10.2147/COPD.S16347229881266
  • LenferinkA, van der PalenJ, van der ValkP, et al. Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial. Eur Respir J. 2019;54:5. doi:10.1183/13993003.02134-2018
  • FoglioK, BianchiL, BrulettiG, et al. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med. 2007;101(9):1961–1970. doi:10.1016/j.rmed.2007.04.00717531455
  • JonesSE, GreenSA, ClarkAL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax. 2014;69(2):181–182. doi:10.1136/thoraxjnl-2013-20422723945168